Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
13,286,327
-
Share change
-
+362,258
-
Total reported value
-
$52,483,948
-
Put/Call ratio
-
135%
-
Price per share
-
$3.95
-
Number of holders
-
64
-
Value change
-
+$1,086,275
-
Number of buys
-
21
-
Number of sells
-
31
Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q1 2017
As of 31 Mar 2017,
SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,286,327 shares.
The largest 10 holders included
Wildcat Capital Management, LLC, Cormorant Asset Management, LLC, BlackRock Inc., VANGUARD GROUP INC, venBio Select Advisor LLC, Intellectus Partners, LLC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and FRANKLIN RESOURCES INC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.